Considering that renal fibrosis is pivotal in the development of renal failure, we hypothesize that a selective removal of LBP might represent a future therapeutic strategy with a significant impact on short- and long-term outcomes for patients with LPS-induced AKI. The gene discussed is LBP; the disease is kidney failure.